A detailed history of Northwest Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Northwest Capital Management Inc holds 200 shares of LLY stock, worth $152,942. This represents 0.07% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$152,942
Previous $177,000 -0.0%
% of portfolio
0.07%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$724.87 - $909.04 $20,296 - $25,453
-28 Reduced 12.28%
200 $181,000
Q4 2023

Feb 01, 2024

SELL
$525.19 - $619.13 $3,151 - $3,714
-6 Reduced 2.56%
228 $132,000
Q2 2023

Aug 03, 2023

BUY
$350.74 - $468.98 $82,073 - $109,741
234 New
234 $109,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $727B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Northwest Capital Management Inc Portfolio

Follow Northwest Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Capital Management Inc with notifications on news.